The past few years have actually seen districts increase, with Nobel ADDING several new regional Managers amd Procera Specialists along with 50 plus head count on reps
Overall Nobel has been gaining market share without having to incorporate a low cost offering
Good docs know that the Science sides with Nobel. We have been at this long enough for all of us to know that Nobel has solid 10 year retrospectives etc etc the ITI is putting out studies showing Nobel Procera abutments being superior to Straumann ....Danaher has let them do their thing...and the digital partnership with Icat and Kavo is promising to say the least
Looks like Nobel will continue to run strong for the foreseeable future as long as docs continue to care about Science and Quality for their patient base